Evidence map›Paper›PMID 39273251›Full record

ReviewInternational journal of molecular sciences2024

Decoding the Role of Insulin-like Growth Factor 1 and Its Isoforms in Breast Cancer.

Amalia Kotsifaki, Sousanna Maroulaki, Efthymios Karalexis, Martha Stathaki, Athanasios Armakolas

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Bladder cancer risk factors: a comprehensive umbrella review of meta-analyses.International journal of surgery (London, England) · 2026
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Investigating Vitamin DMolecular diversity · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amalia KotsifakiPhysiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Sousanna MaroulakiPhysiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Efthymios KaralexisPhysiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Martha StathakiSurgical Clinic, "Elena Venizelou" General Hospital, 11521 Athens, Greece.ORCID 0009-0003-0998-6195
Athanasios ArmakolasPhysiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin-like Growth Factor-1 (IGF-1) is a crucial mitogenic factor with important functions in the mammary gland, mainly through its interaction with the IGF-1 receptor (IGF-1R). This interaction activates a complex signaling network that promotes cell proliferation, epithelial to mesenchymal transition (EMT) and inhibits apoptosis. Despite extensive research, the precise molecular pathways and intracellular mechanisms activated by IGF-1, in cancer, remain poorly understood. Recent evidence highlights the essential roles of IGF-1 and its isoforms in breast cancer (BC) development, progression, and metastasis. The peptides that define the IGF-1 isoforms-IGF-1Ea, IGF-1Eb, and IGF-1Ec-act as key points of convergence for various signaling pathways that influence the growth, metastasis and survival of BC cells. The aim of this review is to provide a detailed exami-nation of the role of the mature IGF-1 and its isoforms in BC biology and their potential use as possible therapeutical targets.

Indexed as

Breast NeoplasmsInsulin-Like Growth Factor IProtein IsoformsAnimalsCell ProliferationEpithelial-Mesenchymal TransitionFemaleHumansInsulin-Like PeptidesReceptor, IGF Type 1Signal TransductionIGF1 protein, humanInsulin-Like Growth Factor IInsulin-Like PeptidesProtein IsoformsReceptor, IGF Type 1apoptosis inhibitionbreast cancer (BC)cancer metasta-sisIGF-1 isoformsIGF-1 receptor (IGF-1R)insulin-like growth factor-1 (IGF-1)novel anti-cancer agentsoncogenic signaling pathwayssignal transductiontherapeutic targetstumorigenesis

Identifiers

PMID39273251
PMCPMC11394947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.